PeerVoice Internal Medicine Audio

Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic Disease

Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative

David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real World

Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer

Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke Prevention

Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer

Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice

Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care Professional

Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology Masterclass

Jonathan Barratt, PhD, FRCP - From Mechanisms to Action: Exploring the Therapeutic Potential of Complement Inhibition in IgA Nephropathy

Suxia Wang, MD - Expert Perspective on the Diagnostic Pathways for Glomerular Diseases

Dirk R. J. Kuypers, MD, PhD - Predicting and Achieving Long-Term Graft Survival in Solid Organ Transplant Recipients: On Track or a Challenge Too Far?

Bradley P. Dixon, MD, FASN / Carla M. Nester, MD, MSA, FASN - Getting to the Root of the Problem: Unlocking the Potential of Novel Complement Inhibitors in C3G and IC-MPGN

Carla M. Nester, MD, MSA, FASN - Closing the Diagnostic Gap: Quick Fire Essentials in C3G and IC-MPGN

Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

Carla M. Nester, MD, MSA, FASN - Novel Therapies in Focus: Updates in C3 Glomerulopathy and IC-MPGN

Pamela Kushner, MD, FAAFP / Magdalena Madero, MD - Taking the Updated CKD Guidelines From Paper to Practice

Gilles Salles, MD, PhD - Differentiating Decisions in Transplant-Ineligible Relapsed/Refractory DLBCL: What Are Our Options, and How Do We Choose Between Them?

Angela Kay Fitch, MD, FACP, MFOMA - Unpacking Impressions and Perceptions of Novel Treatments for Obesity: How Would You Respond to These Questions in Primary Care?

Ronald F. van Vollenhoven, MD, PhD - Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus

Eugen Feist, MD - Anwendung der ersten deutschen AOSD-Therapieleitlinien: die Rolle und Position von Biologika

Michael H. Hsieh, MD, PhD, FASTMH - Differentiating UTIs From STIs in Primary Care: Cases in Practice

Jonathan Barratt, PhD, FRCP - In Pursuit of Proteinuria: Novel Therapeutic Approaches in the Management of IgAN

Differentiating UTIs From STIs in Primary Care: Cases in Practice

Mission Remission: Can This Be Achieved in the Management of Axial Spondyloarthritis?